Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enhabit Inc.

EHAB
Current price
7.44 USD -0.1 USD (-1.33%)
Last closed 7.61 USD
Company
ISIN US29332G1022
Sector Healthcare
Industry Medical Care Facilities
Exchange NYSE
Capitalization 396 735 232 USD
Yield for 12 month -23.93 %
1Y
3Y
5Y
10Y
15Y
EHAB
21.11.2021 - 28.11.2021

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas. Address: 6688 N. Central Expressway, Dallas, TX, United States, 75206

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.05 USD

P/E ratio

Dividend Yield

Current Year

+1 046 300 000 USD

Last Year

+1 083 100 000 USD

Current Quarter

+253 600 001 USD

Last Quarter

+260 600 000 USD

Current Year

+479 800 000 USD

Last Year

+557 500 000 USD

Current Quarter

-27 799 999 USD

Last Quarter

+121 200 000 USD

Key Figures EHAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 70 200 000 USD
Operating Margin TTM 3.9 %
PE Ratio
Return On Assets TTM 1.77 %
PEG Ratio
Return On Equity TTM -17.46 %
Wall Street Target Price 9.05 USD
Revenue TTM 1 037 200 000 USD
Book Value 11.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.8 %
Dividend Yield
Gross Profit TTM 545 500 000 USD
Earnings per share -2.33 USD
Diluted Eps TTM -2.33 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -92 %
Profit Margin -11.24 %

Dividend Analytics EHAB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EHAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EHAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 24.7525
Enterprise Value Revenue 0.8986
Price Sales TTM 0.3825
Enterprise Value EBITDA 14.4289
Price Book MRQ 0.7008

Financials EHAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EHAB

For 52 weeks

6.85 USD 11.74 USD
50 Day MA 7.59 USD
Shares Short Prior Month 3 407 085
200 Day MA 9.04 USD
Short Ratio 1.77
Shares Short 1 675 271
Short Percent 5.52 %